T2 Biosystems Inc. closed its public offering of common stock with gross proceeds of $52.6 million.
The Lexington, Mass.-based company offered 7,015,000 shares, including 915,000 shares pursuant to the full exercise of the underwriters' overallotment option, at $7.50 per share.
Leerink Partners LLC served as the book-running manager for the offering, while Canaccord Genuity LLC acted as the passive book-running manager.
Janney Montgomery Scott LLC, JonesTrading Institutional Services LLC and WBB Securities LLC served as co-managers for the offering.
